EGFR and Skin rash: Among the G3–G4 AEs, diarrhea was more frequent in the 5FU/LV cohort (9.1%), while skin rash was more frequent in the 5FU/LV+anti-EGFR and anti-EGFR cohorts (8.5% and 9.1%, respectively).